Docket Room
A 4915·NJ·house

Requires health insurance coverage for early-stage kidney disease screening without cost sharing.

In CommitteeFiled May 7, 2026
Sponsor: Stewart, Kenyatta
Latest Action

Introduced First Reading Assembly Referred to AFI

May 7, 2026

Summary

The bill mandates that health insurance contracts in New Jersey must pay for early‑stage kidney disease screening when a physician determines it is medically necessary, without any deductible, copayment, or coinsurance. It applies to hospital, medical and health service corporation plans, including high‑deductible and catastrophic plans, as far as federal law allows. The covered screening tests are an estimated glomerular filtration rate blood test or a urine albumin‑creatinine ratio test.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when A 4915 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice